Sunesis Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 64   

Articles published

SNSS 7.49 -0.29 (-3.73%)
price chart
Wedbush Downgrades Sunesis Pharmaceuticals Inc. (SNSS) to Neutral
Wedbush downgraded Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS) from Outperform to Neutral with a price target of $10 (unchanged).
Sunesis Pharmaceuticals major shareholder Sells $2125599 in Stock (SNSS)  WKRB News
Sunesis Pharmaceuticals CEO Unloads 5000 Shares (SNSS)  Watch List News (press release)
Related articles »  
Sunesis Pharmaceuticals, Inc. Offers A Moderate Risk 80% Return On The Short ...
Sunesis Pharmaceuticals is nearing a binary event with the top-line data readout of its Phase 3 Valor trial that is expected any day now.
Related articles »  
Sunesis Pharmaceuticals, Inc. (SNSS) Jumps: Stock Rises 9%
Sunesis Pharmaceuticals, Inc. (SNSS - Snapshot Report) was a big mover last session, as the company saw its shares rise more than 9% on the day.
Related articles »  
Biotech Sector's Great Run: Amicus Therapeutics, Inc. (FOLD), Sunesis ...
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) scored more than 3-year high after an analyst said success is �more likely than not� for the company's development drug for leukemia.
Notable Downgrades: Splunk Inc (SPLK), Mobile TeleSystems (MBT), Sunesis ...
Analysts at Wedbush downgraded shares of Sunesis Pharmaceuticals, Inc.(NASDAQ:SNSS) to 'Neutral' from 'Outperform'.
Related articles »  
Massive Stock Sale at Sunesis Pharmaceuticals, Inc. (SNSS): 4 Insiders Unload ...
Yesterday, Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) saw four of its insiders complete stock dispositions. The first three insiders to unload stock were James Barrett, Patrick Kerins, and Peter Barris, all of whom own over 10% of the company.
Insider Selling: Sunesis Pharmaceuticals Director Unloads 743700 Shares of ...  WKRB News
Sunesis Pharmaceuticals major shareholder Equity Opportunities Fu Growth ...  Watch List News (press release)
Related articles »  
Live News Buzz: IGI Laboratories, Inc.(NYSEMKT:IG), Sunesis Pharmaceuticals ...
Lakeway, NY - (MARKET NEWS CALL) - 8/29/2014�, an investment community with a special focus on updating investors with recent news on the U.S.
Insider Selling: Sunesis Pharmaceuticals major shareholder Sells 300700 ...
The stock had a trading volume of 1,901,954 shares. Sunesis Pharmaceuticals has a one year low of $3.84 and a one year high of $8.46.
Sunesis Pharmaceuticals Rating Lowered to Neutral at Wedbush (SNSS)
Sunesis Pharmaceuticals, Inc. logo Wedbush cut shares of Sunesis Pharmaceuticals (NASDAQ:SNSS) from an outperform rating to a neutral rating in a research report sent to investors on Friday morning, TheFlyOnTheWall.
Momentum Stocks : Family Dollar Stores Inc. (NYSE:FDO), Sunesis ...
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) on Aug. 5 reported financial results for the quarter ended June 30, 2014.